89Bio operates as a clinical-stage biopharmaceutical company. The company focuses on developing therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders. The company serves customers in the United States and Israel.
AppFolio provides industry-specific, cloud-based business software solutions, services and data analytics. The company's solutions include: AppFolio Property Manager, a cloud-based software solution that provides tools and services designed to streamline their property management businesses; AppFolio Investment Management, a cloud-based software solution for real estate investment managers of various sizes providing tools and services designed to streamline their real estate investment management businesses; and MyCase, a cloud-based software solution for the legal market that provides small law firms tools and services designed to streamline their legal practice and manage their caseload.
Hudson Global provides recruitment and related talent solutions. The company's main service offerings include Recruitment Process Outsourcing (RPO) consisting of RPO Recruitment and RPO Contracting. The company provides recruitment outsourcing, project-based outsourcing, and recruitment consulting for clients' permanent staff hires. The company's RPO Recruitment services utilizes its consultants, supported by its specialists in the delivery of its proprietary methods. RPO Contracting provides RPO clients with a range of outsourced personnel contract staffing services and managed service provider services provided sometimes on a standalone basis and sometimes as part of a blended total talent solution.
Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.
Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.
Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.
InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.